Is metformin the treatment of choice for anovulation in polycystic ovary syndrome? 2007

Adam H Balen
Reproductive Medicine Unit, Leeds General Infirmary, Belmont Grove, Leeds, UK. adam.balen@leedsth.nhs.uk

UI MeSH Term Description Entries
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000858 Anovulation Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy. Anovulations
D050177 Overweight A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".
D040242 Risk Reduction Behavior Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives. Risk Reduction,Lifestyle Risk Reduction,Behavior, Risk Reduction,Behaviors, Risk Reduction,Lifestyle Risk Reductions,Risk Reduction Behaviors

Related Publications

Adam H Balen
April 2003, Obstetrics and gynecology,
Adam H Balen
February 2016, Medizinische Monatsschrift fur Pharmazeuten,
Adam H Balen
January 2005, Akusherstvo i ginekologiia,
Adam H Balen
January 1998, Steroids,
Adam H Balen
January 2008, The New England journal of medicine,
Adam H Balen
February 2004, Minerva ginecologica,
Adam H Balen
January 1995, Advances in endocrinology and metabolism,
Adam H Balen
January 2008, Current pharmaceutical design,
Copied contents to your clipboard!